1-12 of 12
Mei S. Duh, ScD, MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adherence to Iron Chelation Therapy and Associated Healthcare Resource Utilization and Costs in Medicaid Patients with Sickle Cell Disease

Francis Vekeman, MA, Medha Sasane, BPharm, PhD, Wendy Y Cheng, MPH, MPhil, Agnihotram V Ramanakumar, PhD, Jonathan Fortier, MA, Mei S. Duh, ScD, MPH, Carole Paley, MD, Patricia Adams-Graves, MD
Journal: Blood
Blood (2014) 124 (21): 2177.
https://doi.org/10.1182/blood.V124.21.2177.2177
Published: 2014
Journal Articles

Medical Complications In Patients With Myelofibrosis By Frequency Of Blood Transfusion and Iron Chelation Therapy

Francis Vekeman, MA, Wendy Y Cheng, MPH, MPhil, Medha Sasane, BPharm, PhD, Lynn Huynh, MPH, MBA, DrPH, Michael Kaminsky, BA, Mei S. Duh, ScD, MPH, Carole Paley, MD, Ruben A. Mesa, MD
Journal: Blood
Blood (2013) 122 (21): 2964.
https://doi.org/10.1182/blood.V122.21.2964.2964
Published: 2013
Journal Articles

Transition From Pediatric To Adult Care Of High Cost Patients In a Medicaid Population With Sickle Cell Disease

Morey A. Blinder, MD, Medha Sasane, BPharm, PhD, Jonathan Fortier, MA, Carole S. Paley, MD, Mei S. Duh, ScD, MPH, Francis Vekeman, MA
Journal: Blood
Blood (2013) 122 (21): 2927.
https://doi.org/10.1182/blood.V122.21.2927.2927
Published: 2013
Journal Articles

High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia A Oneal, MD, Medha Sasane, BPharm, PhD, Francis Vekeman, MA, Christine Bieri, MBA, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Abigail Adams, BA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2013) 122 (21): 982.
https://doi.org/10.1182/blood.V122.21.982.982
Published: 2013
Journal Articles

Age-Related Emergency Department Reliance and Healthcare Resource Utilization in Patients with Sickle Cell Disease

Morey A. Blinder, MD, Francis Vekeman, MA, Medha Sasane, BPharm, PhD, Alex Trahey, BS, Carole Paley, MD, Matthew Magestro, MBA, MS, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2012) 120 (21): 475.
https://doi.org/10.1182/blood.V120.21.475.475
Published: 2012
Journal Articles

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia Ann Oneal, MD, Francis Vekeman, MA, Christine Bieri, MBA, Medha Sasane, BPharm, PhD, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Zachary Gorn, BA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2012) 120 (21): 2106.
https://doi.org/10.1182/blood.V120.21.2106.2106
Published: 2012
Journal Articles

The Cost-Effectiveness of Bortezomib Plus Melphalan and Prednisone Versus Lenalidomide Plus Melphalan and Prednisone with Continuous Lenalidomide Maintenance Treatment for the Initial Treatment of Multiple Myeloma In the United States

Si-Tien Wang, MS, Hui Huang, PhD, MBA, Abbie Ba-Mancini, BS, MBA, Hongliang Shi, MS, Kristina Chen, MS, Caroline Korves, ScD, Ravinder Dhawan, PhD, Andrew Cakana, FRCPath, MD, Helgi van de Velde, Dixie-Lee W. Esseltine, MD, FRCPC, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2010) 116 (21): 2563.
https://doi.org/10.1182/blood.V116.21.2563.2563
Published: 2010
Journal Articles

Monitoring and Treatment of Transfusional Iron Overload: Findings from an Electronic Medical Records Review Study at the Moffitt Cancer Center and Research Institute.

Leslie A Ray, PharmD, Gene A. Wetzstein, PharmD, BCOP, Si-Tien Wang, MS, Amy Guo, PhD, Caroline Korves, ScD, Bentley Clinton, BA, Robert Wei, BA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2010) 116 (21): 1503.
https://doi.org/10.1182/blood.V116.21.1503.1503
Published: 2010
Journal Articles

Treatment of MDS Related Transfusion-Dependent Anemia with Epoetin alfa: A Meta-Analysis Perspective.

Suneel Mundle, PhD, Patrick Lefebvre, MA, Mei S. Duh, ScD, MPH, Francis Vekeman, MA, Behin Yektashenas, PharmD, Francois Laliberté, MA, Victor Moyo, MD
Journal: Blood
Blood (2007) 110 (11): 1471.
https://doi.org/10.1182/blood.V110.11.1471.1471
Published: 2007
Journal Articles

Drug Utilization and Cost Considerations of Erythropoiesis-Stimulating Agents in Patients with Myelodysplastic Syndromes.

François Laliberté, MA, Scott R. McKenzie, MD, Brahim K. Bookhart, MBA, MPH, Mei S. Duh, ScD, MPH, Patrick Lefebvre, MA
Journal: Blood
Blood (2007) 110 (11): 4611.
https://doi.org/10.1182/blood.V110.11.4611.4611
Published: 2007
Journal Articles

Impact of Limiting Erythropoiesis-Stimulating Agent Use for Chemotherapy-Induced Anemia on the United States Blood Supply.

Francis Vekeman, MA, Brahim K. Bookhart, MBA, MPH, Mei S. Duh, ScD, MPH, Scott R. McKenzie, MD, Patrick Lefebvre, MA, Catherine Tak Piech, MBA
Journal: Blood
Blood (2007) 110 (11): 2896.
https://doi.org/10.1182/blood.V110.11.2896.2896
Published: 2007
Journal Articles

Medical Visit Patterns in Cancer Chemotherapy Patients Receiving Erythropoiesis-Stimulating Agents in a Managed Care Setting.

Scott R. McKenzie, MD, Patrick Lefebvre, MA, Brahim K. Bookhart, MBA, MPH, François Laliberté, MA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2007) 110 (11): 5156.
https://doi.org/10.1182/blood.V110.11.5156.5156
Published: 2007